James K. Fong serves as Executive at CTI BIOPHARMA CORP, where they oversee executive responsibilities. Since joining the company, James K. Fong has executed 3 insider transactions totaling $600.0K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jun 26, 2023 involved transacting 3,565 shares valued at $32.4K.
James K. Fong currently holds 103,565 shares of CTI BIOPHARMA CORP (CTIC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James K. Fong has been a net seller of CTIC stock. They have purchased $0 and sold $600.0K worth of shares.
James K. Fong's most recent insider trade was on Jun 26, 2023, when they sold 3,565 shares at $9.10 per share.
Get notified when new Form 4 filings are submitted
| 100,000 |
| $0.95 |
| Discretionary |
| Jan 24, 2023 | CTIC | $600.0K | Sale | 100,000 | $6.00 | Discretionary |